The 20 Best Primitive Neuroectodermal Tumor (PNET) Doctors near Monroeville, PA

Rahul J. Kumar, MD, is a radiation oncologist specializing in the treatment of all radiation oncology cases. Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Laryngeal Cancer, Prostate Cancer, Familial Prostate Cancer, and Breast Cancer.

Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer. Dr. Drappatz is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

Shirley Ong, MD, specializes in hematology oncology and is board-certified in neurology by the American Board of Psychiatry and Neurology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ong received her medical degree from the University of the East Ramon Magsaysay Memorial Medical Center and completed her residency at Saint Louis University School of Medicine, followed by a fellowship at the University of Texas MD Anderson Cancer Center. Dr. Ong is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Steven Burton, MD, is an associate professor of radiation oncology at the University of Pittsburgh School of Medicine. Dr. Burton holds an interest in stereotactic radiosurgery, lymphoma, lung cancer, pancreas cancer, and spinal metastasis. Dr. Burton is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery.

Dr. Zinn is assistant professor of neurological surgery at the University of Pittsburgh School of Medicine and associate director of the Adult Neurosurgical Oncology Program. He specializes in neurosurgical oncology.Dr. Zinn received his medical degree from the University of Zurich in Switzerland and received his PhD from the University of Lausanne. He completed his neurosurgery residency at Baylor College of Medicine and MD Anderson Cancer Center. He then completed a fellowship at Dana-Farber Cancer Institute, Harvard Medical School.In addition to his clinical focus in neuro-oncology, Dr. Zinn’s research focuses on patient-centered care for brain and spinal tumors. Utilizing humanoid brain organoid cancer models, Dr. Zinn simulates the patient’s tumor condition in the laboratory and studies the origins of how the tumor forms and how tumors can be treated using tumor genetics precision approaches. Furthermore, Dr. Zinn is developing personalized biologically-adaptable and patient-tailored, virus-based therapies for brain cancer.Pascal Zinn, MD, PhD, specializes in surgical oncology and neurosurgery. He practices at University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Shadyside. He completed his residency at Baylor College of Medicine and medical degree at University of Zurich. Dr. Zinn is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Cordotomy.

Dr. Lunsford is the Lars Leksell Professor and Distinguished Professor of neurological surgery at the University of Pittsburgh School of Medicine. He is also the director of the Center for Image-Guided Neurosurgery and the Residency Training Program at UPMC. Dr. Lunsford is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Meningioma, Acoustic Neuroma, Schwannoma, Gamma Knife Radiosurgery, and Rhizotomy.

Ajay Niranjan, MD, specializes in neurosurgery. He practices at the University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Presbyterian.  Dr. Niranjan is associate professor of neurological surgery at the University of Pittsburgh School of Medicine. He received his medical degree from King George’s Medical College in Lucknow, India, where he also completed his neurosurgical residency. Dr. Niranjan then completed a fellowship in image-guided neurosurgery at the University of Pittsburgh.A leading expert on stereotactic radiosurgery, Dr. Niranjan has helped develop guidelines for stereotactic radiosurgery for trigeminal neuralgia, pituitary adenomas, arteriovenous malformations, acoustic neuromas, and brain metastases.Dr. Niranjan has co-authored more than 120 articles in journals such as Neurosurgery, Journal of Neurosurgery, and Journal of Neuro-oncology; contributed more than 55 book chapters; and edited two books on stereotactic radiosurgery. Dr. Niranjan is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Schwannoma, Brain Tumor, Metastatic Brain Tumor, Gamma Knife Radiosurgery, and Rhizotomy.

John C. Flickinger, MD, FACR, is a professor of radiation oncology and neurological surgery at the University of Pittsburgh School of Medicine. Dr. Flickinger holds an interest in spine tumors, brain tumors, metastatic diseases, effects of radiation on normal tissue, and the mathematical modeling of radiation response. Dr. Flickinger is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Meningioma, Metastatic Brain Tumor, Glioblastoma, Astrocytoma, and Gamma Knife Radiosurgery.

Dhaval R. Mehta, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Mehta treats all types of cancer and has special interest in hematological disorders and solid tumors, and clinical trials in the community setting. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Familial Pancreatic Cancer, and Neuroendocrine Tumor.

Nishant Tageja, MD, is a medical oncologist and hematologist. Dr. Tageja specializes in the treatment of solid tumors such as breast cancer, lung cancer, and colon cancer as well as treatment of all benign and malignant blood disorders including lymphoma, leukemia, and myeloma. Dr. Tageja is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Familial Colorectal Cancer, and Bone Marrow Transplant.

Khanh Nguyen, MD, specializes in medical oncology and practices with UPMC Hillman Cancer Center and is affiliated with UPMC East and UPMC Magee-Womens Hospital. Dr. Nguyen completed his medical education at the Medical College of Georgia and is board certified in Medical Oncology by the American Board of Internal Medicine. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Breast Cancer.

Thomas Nabhani, MD, specializes in radiation oncology and is board-certified by the American Board of Radiology. He practices at UPMC Hillman Cancer Center and Mountain View Cancer Associates. Dr. Nabhani completed his medical degree at the University of Illinois College of Medicine, residency at Johns Hopkins University School of Medicine and SUNY Downstate Health Sciences University, and fellowship at UCLA Department of Surgery. Dr. Nabhani is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Throat Cancer, Laryngeal Cancer, Prostate Cancer, and Breast Cancer.

Stephen Karlovits is a Radiation Oncologist and a Radiologist in Pittsburgh, Pennsylvania. Dr. Karlovits is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Breast Cancer, and Metastatic Brain Tumor.

Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).

Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Prostate Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.

Daniel P. Petro, MD, is a medical oncologist and hematologist at Hillman Cancer Center. He treats all cancer types, and has a special interest in a multidisciplinary approach to thoracic malignancies. Dr. Petro is also heavily involved in the research of Phase I trials. Dr. Petro is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Awake Craniotomy.

Megan M. Mantica, MD, is an assistant professor of neurology and medicine at the University of Pittsburgh School of Medicine in the division of hematology/oncology. She specializes in the treatment of adult high grade gliomas, central nervous system lymphoma, and neurological complications of cancer treatment. Her translational research interests include womenís neuro-oncology, reproductive neuro-oncology and metastatic brain disease, and high grade gliomas. Dr. Mantica is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, and Astrocytoma.

Jaime Mullin, DO, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Mullin is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Posterior Fossa Tumor, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Gastrostomy.

John K. Waas, DO, is a medical oncologist at UPMC Hillman Cancer Center who practices at Arnold Palmer Medical Oncology at Norwin. Board-certified in medical oncology, Dr. Waas received his medical degree from Philadelphia College of Osteopathic Medicine in Philadelphia. He completed his residency at Lehigh Valley Hospital Center in Allentown, Pa. Dr. Waas is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Congenital Antithrombin 3 Deficiency, Protein C Deficiency, Protein S Deficiency, and Hereditary Resistance to Anti-Vitamin K.